Bisantrene Combination for Resistant AML

Clinical trial NCT04989335 · UNKNOWN

Trial details

NCT number: NCT04989335
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelogenous Leukemia, Acute

Start date: 2021-08-02
Primary completion: 2024-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.